1025 related articles for article (PubMed ID: 25822019)
1. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
2. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
Front Immunol; 2018; 9():2247. PubMed ID: 30323818
[No Abstract] [Full Text] [Related]
4. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
5. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
6. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
7. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.
Petruccioli E; Petrone L; Vanini V; Cuzzi G; Navarra A; Gualano G; Palmieri F; Girardi E; Goletti D
J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021
[TBL] [Abstract][Full Text] [Related]
8. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
9. Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection.
Silveira-Mattos PS; Barreto-Duarte B; Vasconcelos B; Fukutani KF; Vinhaes CL; Oliveira-De-Souza D; Ibegbu CC; Figueiredo MC; Sterling TR; Rengarajan J; Andrade BB
Clin Infect Dis; 2020 Nov; 71(8):1905-1911. PubMed ID: 31665254
[TBL] [Abstract][Full Text] [Related]
10. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
[TBL] [Abstract][Full Text] [Related]
11. High Frequencies of Caspase-3 Expressing
Adekambi T; Ibegbu CC; Cagle S; Ray SM; Rengarajan J
Front Immunol; 2018; 9():1481. PubMed ID: 29983703
[TBL] [Abstract][Full Text] [Related]
12. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.
Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I
Front Microbiol; 2022; 13():885312. PubMed ID: 35935194
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
[TBL] [Abstract][Full Text] [Related]
15. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
16. CD137 is a Useful Marker for Identifying CD4
Yan ZH; Zheng XF; Yi L; Wang J; Wang XJ; Wei PJ; Jia HY; Zhou LJ; Zhao YL; Zhang HT
Scand J Immunol; 2017 May; 85(5):372-380. PubMed ID: 28218958
[TBL] [Abstract][Full Text] [Related]
17. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
Balfour A; Schutz C; Goliath R; Wilkinson KA; Sayed S; Sossen B; Kanyik JP; Ward A; Ndzhukule R; Gela A; Lewinsohn DM; Lewinsohn DA; Meintjes G; Shey M
Front Immunol; 2021; 12():648216. PubMed ID: 33828558
[No Abstract] [Full Text] [Related]
18. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
[TBL] [Abstract][Full Text] [Related]
19. Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.
Li Y; Zhu Y; Zhou L; Fang Y; Huang L; Ren L; Peng Y; Li Y; Yang F; Xie D; Tang W; Zhang N; Zhong Q; Lai X
Immunobiology; 2011 Aug; 216(8):947-60. PubMed ID: 21281984
[TBL] [Abstract][Full Text] [Related]
20. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
